Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia (2018)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.atherosclerosis.2018.06.010
- Subjects: HIPERCOLESTEROLEMIA; ADESÃO À MEDICAÇÃO; SENSO COMUM
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 277, p. 493-501, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HAGGER, Martin S e SANTOS FILHO, Raul Dias dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis, v. 277, p. 493-501, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.06.010. Acesso em: 22 jan. 2026. -
APA
Hagger, M. S., & Santos Filho, R. D. dos. (2018). Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis, 277, 493-501. doi:10.1016/j.atherosclerosis.2018.06.010 -
NLM
Hagger MS, Santos Filho RD dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia [Internet]. Atherosclerosis. 2018 ; 277 493-501.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.010 -
Vancouver
Hagger MS, Santos Filho RD dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia [Internet]. Atherosclerosis. 2018 ; 277 493-501.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.010 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
- Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials [Editorial]: more data still necessary
Informações sobre o DOI: 10.1016/j.atherosclerosis.2018.06.010 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
